Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Assessment of a tumour’s mutational profile offers a way of predicting a person’s response to anticancer therapies called immune-checkpoint inhibitors. It seems that such approaches might fall short for people who are not of European ancestry.
Convergent mutations in hotspots of the SARS-CoV-2 Omicron receptor-binding domain can cause immune evasion and maintain sufficient ACE2-binding capability.
Conservationist Eileen Maher uses large spheres made of shells, sand and cement to prevent erosion and attract oysters as part of her work to manage tidelands around a Southern Californian port.
Pfizer and GSK are racing to get approval for the first-ever jabs against respiratory syncytial virus. Plus, nine stark charts show how UK science is failing Black researchers and the best science books to read this week.
Market turmoil and geopolitical realignment after Russia’s invasion of Ukraine put livelihoods and the green-energy transition at risk. Here’s how researchers can help overcome the threats.
The people behind this year’s biggest science stories. Plus, the James Webb Space Telescope scrutinizes seven Earth-sized planets and the satellite that will track all of the world’s water.
From Russia’s invasion of Ukraine to predicting protein structures with AI and transplanting pig organs into people, our news editors choose the defining moments in science this year.